Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Testosterone Treatment and Cardiovascular and Venous Thromboembolism Risk: What is ‘New’?
Giovanni Corona, Mauro Dicuio, Giulia Rastrelli, et al.
Journal of Investigative Medicine (2017) Vol. 65, Iss. 6, pp. 964-973
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

European Academy of Andrology (EAA) guidelines on investigation, treatment and monitoring of functional hypogonadism in males
Giovanni Corona, Dimitrios G. Goulis, Ilpo Huhtaniemi, et al.
Andrology (2020) Vol. 8, Iss. 5, pp. 970-987
Open Access | Times Cited: 308
Adult- and late-onset male hypogonadism: the clinical practice guidelines of the Italian Society of Andrology and Sexual Medicine (SIAMS) and the Italian Society of Endocrinology (SIE)
Andrea M. Isidori, Antônio Aversa, Aldo E. Calogero, et al.
Journal of Endocrinological Investigation (2022) Vol. 45, Iss. 12, pp. 2385-2403
Open Access | Times Cited: 75
Endogenous Testosterone Levels and Cardiovascular Risk: Meta-Analysis of Observational Studies
Giovanni Corona, Giulia Rastrelli, Giuseppe Di Pasquale, et al.
The Journal of Sexual Medicine (2018) Vol. 15, Iss. 9, pp. 1260-1271
Open Access | Times Cited: 148
Testosterone and Cardiovascular Risk: Meta-Analysis of Interventional Studies
Giovanni Corona, Giulia Rastrelli, Giuseppe Di Pasquale, et al.
The Journal of Sexual Medicine (2018) Vol. 15, Iss. 6, pp. 820-838
Closed Access | Times Cited: 116
Association of Testosterone Therapy With Risk of Venous Thromboembolism Among Men With and Without Hypogonadism
Rob F. Walker, Neil A. Zakai, Richard F. MacLehose, et al.
JAMA Internal Medicine (2019) Vol. 180, Iss. 2, pp. 190-190
Open Access | Times Cited: 109
Prospective evaluation of hematocrit in gender‐affirming hormone treatment: results from European Network for the Investigation of Gender Incongruence
Justine Defreyne, B. Vantomme, Eva Van Caenegem, et al.
Andrology (2018) Vol. 6, Iss. 3, pp. 446-454
Open Access | Times Cited: 97
Testosterone deficiency in non-cancer opioid-treated patients
Flaminia Coluzzi, Domenico Billeci, Mario Maggi, et al.
Journal of Endocrinological Investigation (2018) Vol. 41, Iss. 12, pp. 1377-1388
Open Access | Times Cited: 71
Testosterone therapy and venous thromboembolism: A systematic review and meta-analysis
Damon E. Houghton, Mouaz Alsawas, Patricia Barrioneuvo, et al.
Thrombosis Research (2018) Vol. 172, pp. 94-103
Open Access | Times Cited: 68
Testosterone Therapy: What We Have Learned From Trials
Giovanni Corona, Luiz Otávio Torres, Mario Maggi
The Journal of Sexual Medicine (2020) Vol. 17, Iss. 3, pp. 447-460
Open Access | Times Cited: 63
Society of Family Planning clinical recommendations: Contraceptive counseling for transgender and gender diverse people who were female sex assigned at birth
A. Bonnington, Shokoufeh Dianat, Jennifer Kerns, et al.
Contraception (2020) Vol. 102, Iss. 2, pp. 70-82
Open Access | Times Cited: 50
The complex association between metabolic syndrome and male hypogonadism
Christina Dimopoulou, Dimitrios G. Goulis, Giovanni Corona, et al.
Metabolism (2018) Vol. 86, pp. 61-68
Closed Access | Times Cited: 51
Recommendations on the diagnosis, treatment and monitoring of testosterone deficiency in men
Bruno Lunenfeld, George Mskhalaya, Michael Zitzmann, et al.
The Aging Male (2021) Vol. 24, Iss. 1, pp. 119-138
Open Access | Times Cited: 40
Cardiovascular risk and testosterone – from subclinical atherosclerosis to lipoprotein function to heart failure
Bariş Gencer, Marco Bonomi, Maria Pia Adorni, et al.
Reviews in Endocrine and Metabolic Disorders (2021) Vol. 22, Iss. 2, pp. 257-274
Open Access | Times Cited: 33
The safety of available treatments of male hypogonadism in organic and functional hypogonadism
Giovanni Corona, Giulia Rastrelli, Yacov Reisman, et al.
Expert Opinion on Drug Safety (2018) Vol. 17, Iss. 3, pp. 277-292
Closed Access | Times Cited: 40
Testosterone replacement therapy and the risk of venous thromboembolism: A systematic review and meta-analysis of randomized controlled trials
Henok Tadesse Ayele, Vanessa C. Brunetti, Christel Renoux, et al.
Thrombosis Research (2021) Vol. 199, pp. 123-131
Open Access | Times Cited: 32
Testosterone Therapy, Thrombophilia, Venous Thromboembolism, and Thrombotic Events
Charles J. Glueck, Naila Goldenberg, Ping Wang
Journal of Clinical Medicine (2018) Vol. 8, Iss. 1, pp. 11-11
Open Access | Times Cited: 35
Updated clinical models for VTE prediction in hospitalized medical patients
Grigoris Gerotziafas, Loula Papageorgiou, Stella Salta, et al.
Thrombosis Research (2018) Vol. 164, pp. S62-S69
Closed Access | Times Cited: 33
Late-onset Hypogonadism and Testosterone Therapy – A Summary of Guidelines from the American Urological Association and the European Association of Urology
Mikkel Fode, Andrea Salonia, Suks Minhas, et al.
European Urology Focus (2019) Vol. 5, Iss. 4, pp. 539-544
Closed Access | Times Cited: 32
The complications of male hypogonadism: is it just a matter of low testosterone?
Elisabetta Veronica Munari, Myriam Amer, Alessandro Amodeo, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 8
Controversies in Testosterone Therapy
David K. Twitchell, Alexander W. Pastuszak, Mohit Khera
Sexual Medicine Reviews (2020) Vol. 9, Iss. 1, pp. 149-159
Closed Access | Times Cited: 22
Occurrence of Pulmonary Oil Microembolism After Testosterone Undecanoate Injection: A Postmarketing Safety Analysis
Alexander W. Pastuszak, Yiqun Hu, Jeffrey D. Freid
Sexual Medicine (2020) Vol. 8, Iss. 2, pp. 237-242
Open Access | Times Cited: 18
Hypogonadism and its treatment following ischaemic stroke in men with type 2 diabetes mellitus
L. Yu. Morgunov, I. A. Denisova, T. I. Rozhkova, et al.
The Aging Male (2018) Vol. 23, Iss. 1, pp. 71-80
Open Access | Times Cited: 17
Cardiovascular Risks of Androgen Deprivation Therapy for Prostate Cancer
Giovanni Corona, Sandra Filippi, Nicola Bianchi, et al.
The World Journal of Men s Health (2020) Vol. 39, Iss. 3, pp. 429-429
Open Access | Times Cited: 15
An update on heart disease risk associated with testosterone boosting medications
Giovanni Corona, Giulia Rastrelli, Federica Guaraldi, et al.
Expert Opinion on Drug Safety (2019) Vol. 18, Iss. 4, pp. 321-332
Closed Access | Times Cited: 14
Therapie mit Testosteron
Eberhard Nieschlag, Hermann M. Behre
Springer Reference Medizin (2023), pp. 591-612
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top